The Use of PARP Inhibitors in Cancer Therapy: Use as Adjuvant with Chemotherapy or Radiotherapy, Use as a Single Agent in Susceptible Patients, and Techniques Used to Identify Susceptible Patients-Reference-Cited by-同舟云学术

The Use of PARP Inhibitors in Cancer Therapy: Use as Adjuvant with Chemotherapy or Radiotherapy, Use as a Single Agent in Susceptible Patients, and Techniques Used to Identify Susceptible Patients

Published:2017 Issue: Volume: Page:343-370
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Shall Sydney,Gaymes Terry,Farzaneh Farzin,Curtin Nicola J.,Mufti Ghulam J.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-6993-7_23

Reference37 articles.

1. Doly J, Petek F (1966) tude de la structure d’un compose “poly (ADP-ribose)” synth.tis. par des extraits nucl.ares de foie de poulet. C R Hebd Seances Acad Sci Ser D Sci Nat 263:1341–1344

2. Chambon P, Weill JD, Doly J, Strosser MT, Mandel P (1966) On the formation of a novel adenylic compound by enzymatic extracts of liver nuclei. Biochem Biophys Res Commun 25:638–643

3. Sugimura T, Fujimura S, Hasegawa S, Kawamura Y (1967) Polymerization of the adenosine 5¢-diphosphate ribose moiety of NAD by rat liver nuclear enzyme. Biochim Biophys Acta 138:438–441

4. Nishizuka Y, Ueda K, Nakazawa K, Hayaishi O (1967) Studies on the polymer of adenosine diphosphate ribose. 1. Enzymic formation from nicotinamide dinucleotide in mammalian nuclei. J Biol Chem 242:3164–3171

5. Roitt IM (1956) The inhibition of carbohydrate metabolism in ascites-tumour cells by ethyleneimines. Biochem J 63:300–307

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology;International Journal of Molecular & Immuno Oncology;2020-01-21

2. DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiation;Proceedings of the National Academy of Sciences;2019-10-07

3. Update on current pancreatic treatments: from molecular pathways to treatment;Journal of Cancer;2019

4. Maintenance Treatment for Recurrent Ovarian Carcinoma – Evidence Supporting the Efficacy and Safety of PARP Inhibitors;European Oncology & Haematology;2019

5. Targeting Base Excision Repair Glycosylases with DNA Containing Transition State Mimics Prepared via Click Chemistry;ACS Chemical Biology;2018-11-30